Beta Agonist Feed Additive Market Analysis
The Beta Agonist Feed Additive Market size is estimated at USD 120 billion in 2025, and is expected to reach USD 144 billion by 2030, at a CAGR of 5.90% during the forecast period (2025-2030).
The beta-agonist feed additive market is experiencing robust growth, driven by increasing demand for high-quality meat production, improved animal growth performance, and enhanced feed efficiency. Widely utilized in the livestock industry, particularly in cattle and swine farming, beta-agonists help promote lean muscle growth, reduce fat deposition, and optimize feed utilization. The rising production of livestock is a key factor fueling market growth. For instance, United States swine production increased from 75.0 million in 2022 to 75.8 million in 2023, according to FAOSTAT. Similarly, growing meat consumption has led to higher meat production in countries such as China, the United States, and Argentina. FAOSTAT data indicates that global beef production rose from 75.4 million metric tons in 2022 to 76.6 million metric tons in 2023. As demand for meat continues to surge, especially in emerging economies, livestock producers are increasingly adopting cost-effective solutions to enhance productivity and meet market needs. Furthermore, rising investments in precision livestock farming are contributing to the market’s expansion, creating new opportunities for industry players.
Beta Agonist Feed Additive Market Trends
Increasing Demand for Animal Meat to Drive Beta-Agonist Feed Additive Sales
The beta-agonist feed additive market is expanding in response to the growing pressure on the livestock industry to meet the rising global demand for meat and high-value animal protein. Factors such as population growth, increasing incomes in developing nations, and urbanization are driving a surge in livestock production. Higher income levels are closely linked to increased consumption of animal protein, with milk and meat becoming more prominent in diets at the expense of staple foods. Urbanization, in particular, has led to greater meat and dairy consumption in cities compared to rural areas. For example, according to the OECD, per capita pork consumption in Vietnam, China, and the United States rose in 2023 to 30.3 kg, 28.6 kg, and 21.8 kg, respectively, up from 30.0 kg, 28.0 kg, and 21.7 kg in 2022.
As the global meat market continues its steady growth, meat consumption is expected to register a significant CAGR over the forecast period. The Asia-Pacific and Latin American regions are projected to see the highest increases in meat consumption due to changing dietary patterns, urbanization, population expansion, and economic growth. For instance, China’s demand for meat continues to surpass domestic supply, as reported by Agriculture and Agri-Food Canada.
United States to Dominate the Beta Agonist Feed Additive Sales
The United States remains one of the key markets for beta-agonist feed additives, driven by strong meat consumption trends and the large-scale production of livestock. The increasing demand for high-quality beef and pork continues to stimulate cattle and swine production, further boosting the adoption of beta-agonist feed additives in the country.
In addition to cattle, the rising demand for pork has contributed to increased swine production, further supporting beta-agonist feed additive sales. According to FAOSTAT, US swine production reached 75.8 million in 2023, reflecting a 1.1% increase from the previous year. This steady growth in pork production highlights the ongoing need for feed-efficiency-enhancing additives to maximize output and profitability. With the US being one of the world’s largest consumers and exporters of meat, the beta-agonist feed additive market is projected to remain strong. Ongoing advancements in livestock nutrition, regulatory developments, and producer adoption of growth-promoting technologies will continue to shape market dynamics in the coming years.
Beta Agonist Feed Additive Industry Overview
The beta-agonist feed additives market is consolidated, with few major players offering similar products. The limited scope for product differentiation and innovation has resulted in a concentrated competitive landscape. Some of the major players in the country include Merck Animal Health, Elanco Animal Health, Zoetis, Quality Liquid Feed, and Heer Pharma Private Limited. New product launches following extensive R&D activities have been part of the strategic moves by the players.
Beta Agonist Feed Additive Market Leaders
-
Merck Animal Health
-
Elanco Animal Health
-
Zoetis
-
Quality Liquid Feeds
-
Heer Pharma Private Limited
- *Disclaimer: Major Players sorted in no particular order
Beta Agonist Feed Additive Market News
- March 2024: The Animal Legal Defense Fund, Center for Biological Diversity, Center for Food Safety, and Food Animal Concerns Trust filed a lawsuit requiring the U.S. Food and Drug Administration (FDA) to respond to their 2012 and 2020 rulemaking petitions. These petitions called for reducing or eliminating permitted ractopamine levels in farmed animals.
- :
Beta Agonist Feed Additive Industry Segmentation
Beta-agonists feed additives are used to feed ruminants and swine, especially before slaughtering. They are approved feed additives, which help in escalating lean muscle gain, increasing growth rate, and feed efficiency. It comprises a comprehensive analysis of market segmentation based on type (ractopamine and zilpaterol), animal type (swine, ruminants, and others), and geography (North America, Asia-Pacific, and South America). The report offers market size and forecasts regarding value (USD) and Volume (metric tons) for all the segments.
Type | Ractopamine | ||
Zilpaterol | |||
Animal Type | Swine | ||
Ruminants | |||
Others | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Rest of North America | |||
Asia-Pacific | Japan | ||
South Korea | |||
India | |||
Rest of Asia-Pacific | |||
South America | Brazil | ||
Argentina | |||
Rest of South America | |||
Rest of the World |
Beta Agonist Feed Additive Market Research FAQs
How big is the Beta Agonist Feed Additive Market?
The Beta Agonist Feed Additive Market size is expected to reach USD 120 billion in 2025 and grow at a CAGR of 5.90% to reach USD 144 billion by 2030.
What is the current Beta Agonist Feed Additive Market size?
In 2025, the Beta Agonist Feed Additive Market size is expected to reach USD 120 billion.
Who are the key players in Beta Agonist Feed Additive Market?
Merck Animal Health, Elanco Animal Health, Zoetis, Quality Liquid Feeds and Heer Pharma Private Limited are the major companies operating in the Beta Agonist Feed Additive Market.
Which is the fastest growing region in Beta Agonist Feed Additive Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Beta Agonist Feed Additive Market?
In 2025, the North America accounts for the largest market share in Beta Agonist Feed Additive Market.
What years does this Beta Agonist Feed Additive Market cover, and what was the market size in 2024?
In 2024, the Beta Agonist Feed Additive Market size was estimated at USD 112.92 billion. The report covers the Beta Agonist Feed Additive Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Beta Agonist Feed Additive Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Beta Agonist Feed Additive Industry Report
Statistics for the 2025 Beta Agonist Feed Additive market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Beta Agonist Feed Additive analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.